×
S&P 500   3,831.39
DOW   30,967.82
QQQ   286.96
S&P 500   3,831.39
DOW   30,967.82
QQQ   286.96
S&P 500   3,831.39
DOW   30,967.82
QQQ   286.96
S&P 500   3,831.39
DOW   30,967.82
QQQ   286.96
CVE:MFS

Medifocus Inc. (MFS.V) Stock Forecast, Price & News

C$0.01
0.00 (0.00%)
(As of 09/4/2020)
Add
Compare
Today's Range
C$0.01
C$0.01
50-Day Range
C$0.01
C$0.01
52-Week Range
C$0.01
C$0.02
Volume
26,000 shs
Average Volume
317,764 shs
Market Capitalization
C$1.85 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Medifocus Inc. (MFS.V) MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

0.33 out of 5 stars

30 days | 90 days | 365 days | Advanced Chart

Receive MFS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medifocus Inc. (MFS.V) and its competitors with MarketBeat's FREE daily newsletter.

About Medifocus Inc. (MFS.V)

Medifocus, Inc., a medical technology company, develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate in Canada and the United States. The company owns technology platforms, including Endo-thermotherapy platform, a catheter-based focused heat technology platform that utilizes natural body openings to deliver microwave thermotherapy to the diseased sites; and Adaptive Phased Array (APA) Microwave Focusing platform, which directs focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue. It also offers Prolieve Thermodilatation system, a medical device based on endo-thermotherapy for the treatment of benign prostatic hyperplasia. In addition, the company is developing APA 1000, a minimally invasive breast cancer treatment system, which is in pivotal Phase-III clinical trials. The company has a license agreement with Duke University for the development of heat-activated and tumor-targeted immunotherapy and gene therapy technology for the treatment of cancers and other diseases. Medifocus, Inc. is based in Toronto, Canada.

MFS Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$2.23 million
Cash Flow
C$0.00 per share
Book Value
C($0.07) per share

Miscellaneous

Free Float
N/A
Market Cap
C$1.85 million
Optionable
Not Optionable
Beta
N/A














Medifocus Inc. (MFS.V) Frequently Asked Questions

How has Medifocus Inc. (MFS.V)'s stock performed in 2022?

Medifocus Inc. (MFS.V)'s stock was trading at C$0.01 at the beginning of the year. Since then, MFS shares have increased by 0.0% and is now trading at C$0.01.
View the best growth stocks for 2022 here
.

Who are Medifocus Inc. (MFS.V)'s key executives?

Medifocus Inc. (MFS.V)'s management team includes the following people:
  • Dr. William W. Jow, CEO, Pres & Medical Director (Age 63, Pay $180k)
  • Mr. Charkes C. Shelton, Exec. VP and Gen. Counsel (Age 75)

What other stocks do shareholders of Medifocus Inc. (MFS.V) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medifocus Inc. (MFS.V) investors own include (RLYP) (RLYP), Sangamo Therapeutics (SGMO), Regeneron Pharmaceuticals (REGN), Onconova Therapeutics (ONTX), Intec Pharma (NTEC), FireEye (FEYE), Chevron (CVX), BP Prudhoe Bay Royalty Trust (BPT) and (AAXN).

What is Medifocus Inc. (MFS.V)'s stock symbol?

Medifocus Inc. (MFS.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MFS."

How do I buy shares of Medifocus Inc. (MFS.V)?

Shares of MFS and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Medifocus Inc. (MFS.V)'s stock price today?

One share of MFS stock can currently be purchased for approximately C$0.01.

How much money does Medifocus Inc. (MFS.V) make?

Medifocus Inc. (MFS.V) (CVE:MFS) has a market capitalization of C$1.85 million and generates C$2.23 million in revenue each year.

How many employees does Medifocus Inc. (MFS.V) have?

Medifocus Inc. (MFS.V) employs 7 workers across the globe.

How can I contact Medifocus Inc. (MFS.V)?

Medifocus Inc. (MFS.V)'s mailing address is The Exchange Tower Suite 1800, 130 King Street West, PO Box 427, TORONTO, ON M5X 1E3, Canada. The official website for Medifocus Inc. (MFS.V) is www.medifocusinc.com. The company can be reached via phone at +1-905-3197070.

This page (CVE:MFS) was last updated on 7/6/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.